Process for the preparation of 3-propenyl cephalosporin DMF solvate
    1.
    发明授权
    Process for the preparation of 3-propenyl cephalosporin DMF solvate 失效
    3-丙烯基头孢菌素DMF溶剂化物的制备方法

    公开(公告)号:US06903211B2

    公开(公告)日:2005-06-07

    申请号:US10315010

    申请日:2002-12-10

    CPC分类号: C07D501/00 Y02P20/55

    摘要: The present invention relates to an improved process for the preparation of cefprozil DMF solvate of formula (I), which is useful for the preparation of cefprozil, comprising: i) reacting a compound of formula (VIII) with acetaldehyde to produce a compound of formula (IX), ii) deesterifying the carboxy protecting group of the compound of formula (IX) using an acid to yield a compound of formula (X), iii) converting the compound of formula (X) to a compound of formula (XI), iv) neutralizing the compound of formula (XI) followed by enzymatic hydrolysis to produce an APCA of formula (V), v) silylating the APCA using a mixture of trimethylsilylchloride and hexamethyldisilazane to produce silylated APCA of formula (XII), and vi) condensing the silylated APCA with a mixed anhydride to produce the DMF solvate compound of formula (I).

    摘要翻译: 本发明涉及用于制备式(I)的头孢丙呋胺溶剂化物的改进方法,其可用于制备头孢丙烯,其包括:i)使式(Ⅷ)化合物与乙醛反应以制备式 (Ⅸ)化合物,ⅱ)使用酸去除式(Ⅸ)化合物的羧基保护基,得到式(Ⅹ)化合物,ⅲ)将式(Ⅹ)化合物转化为式(Ⅺ)化合物, iv)中和式(XI)化合物,然后进行酶水解以产生式(V)的APCA,v)使用三甲基甲硅烷基氯和六甲基二硅氮烷的混合物使APCA甲硅烷基化以制备式(XII)的甲硅烷基化APCA,和vi) 用混合酸酐缩合甲硅烷基化APCA以制备式(I)的DMF溶剂合物。